CircuitLife Europe SRL
CircuitLife Europe reported total assets of 49,903 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jul 2026).
The score of CircuitLife Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity -9 % Total assets +11 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CircuitLife Europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jul 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
CircuitLife Europe's financial analysis
- Solvency27.0%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CircuitLife Europe
CircuitLife Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0789.716.590
- VAT number
- BE0789716590
- Peppol
- Registered · 0208:0789716590 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Aug 2022
- Registered office
- 1820 Steenokkerzeel
- Latest accounts
- 2025 · filed on 17 Jul 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
CircuitLife Europe (SRL) has been based in Steenokkerzeel since 2022, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net loss of 1,561 € and equity of 13,496 €; its revenue is not published. Its solvency stands at 27.0%, below the median of its sector (47.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to CircuitLife Europe
Companies in the same business, of comparable size and area, outside its group.
- Arterix Retail sale of medical and orthopaedic goods Destelbergen · balance sheet 9,206 €
- Van Huiden Consultancy Retail sale of medical and orthopaedic goods Antwerp · balance sheet 50,967 €
- Cecosur Retail sale of medical and orthopaedic goods Jette · balance sheet 51,271 €
- Life International Retail sale of medical and orthopaedic goods Schelle · balance sheet 51,768 €
- Auditoor Retail sale of medical and orthopaedic goods Buggenhout · balance sheet 52,161 €
- Medico Retail sale of medical and orthopaedic goods Halle · balance sheet 52,839 €
- Nuclemed Retail sale of medical and orthopaedic goods Roeselare · balance sheet 53,689 €
- Audio Noord Retail sale of medical and orthopaedic goods Antwerp · balance sheet 56,984 €
Frequently asked questions about CircuitLife Europe
What is the revenue of CircuitLife Europe?
CircuitLife Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CircuitLife Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0789716590 for CircuitLife Europe, if the company is VAT-registered. Its company number (CBE) is 0789.716.590.
Where is the registered office of CircuitLife Europe?
According to the CBE register, the registered office of CircuitLife Europe is in 1820 Steenokkerzeel.
What is the equity of CircuitLife Europe?
At the close of the 2025 financial year, the equity of CircuitLife Europe amounts to 13,496 €, a solvency of 27.0% of total assets.
Who manages CircuitLife Europe?
The register lists 1 active mandates at CircuitLife Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CircuitLife Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →